slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 41,461-41,490
Pages 10,126
Rows per page 30
Component
41,461-41,490 of 303,780
50
Aston Martin Lagonda | Investor Day Presentation Deck | 66 slidesAston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Loop · Three Horizons2 hits
52
The image shows a wall listing employee names, reinforcing the 'People' theme. The footer lists core values: UNITY | OPENNESS | TRUST | OWNERSHIP | COURAGE.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Loop · Three Horizons2 hits
53
The slide uses a hub-and-spoke circular process diagram to represent a holistic sustainability strategy.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Loop · Three Horizons2 hits
54
Aston Martin Lagonda | Investor Day Presentation Deck | 66 slidesAston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations 2 hits
58
Aston Martin Lagonda | Investor Day Presentation Deck | 66 slidesAston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Financials2 hits
60
Aston Martin Lagonda | Investor Day Presentation Deck | 66 slidesAston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Financials2 hits
61
The chart uses a waterfall bridge format to explain margin expansion.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Financials2 hits
62
The slide highlights the strategic pivot from internal combustion engines to battery electric vehicles.Aston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations Beat · Financials2 hits
66
Aston Martin Lagonda | Investor Day Presentation Deck | 66 slidesAston Martin Lagonda | Investor Day Presentation Deck | 66 slides · Aston Martin
Conference presentation Investor relations 2 hits
08
AstraZeneca | Investor Event Presentation Deck | 52 slidesAstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction2 hits
09
The diagram illustrates a hub-and-spoke model where the central hub is 'Diverse portfolio for combinations' and the spokes are the various therapeutic areas.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction2 hits
10
The slide uses a timeline framework to highlight key clinical trial milestones.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction2 hits
11
The slide features a headshot of the speaker and a medical illustration of cells.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction2 hits
21
The slide uses a three-column layout to explain the product, the strategy, and the clinical trial pipeline.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After2 hits
22
The slide outlines a clinical trial structure with six cohorts testing different combinations of Dato-DXd, pembrolizumab, and platinum-based chemotherapy.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After2 hits
23
Includes clinical trial abbreviations and definitions in the footer.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After2 hits
24
The chart is a diverging stacked bar chart comparing two treatment arms. Yellow boxes highlight specific hematological toxicities.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After2 hits
25
The slide uses a process flow diagram to map clinical trials to strategic goals.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Before After2 hits
26
Includes spider plot (target lesion change over time) and waterfall plot (best percentage change).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
27
The slide uses a matrix-like layout to categorize clinical trials by disease stage and treatment line.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
28
The slide uses a matrix structure to segment the market by disease stage and molecular profile, overlaying clinical trial names (e.g., AEGEAN, FLAURA) as product markers.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
29
AstraZeneca | Investor Event Presentation Deck | 52 slidesAstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
31
The slide uses a standard clinical trial flow diagram (process flow).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
32
Clinical trial data presentation showing PFS outcomes for Arm 1 (chemo + bev) vs Arm 3 (chemo + bev + durvalumab + olaparib).AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
33
Clinical trial data presentation using Kaplan-Meier plots with associated risk tables and hazard ratios.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
34
The chart is a radial segment diagram showing patient population segments (HRD-negative, HRD-positive non-BRCAm, tBRCAm) and corresponding clinical trials.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
35
The slide outlines the clinical trial methodology, specifically the randomization and treatment arms for advanced endometrial cancer.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
37
The slide outlines a basket trial design for Enhertu across multiple solid tumor types.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
38
The table uses color-coded headers for different tumor types. The 'Best overall response' section is highlighted with a yellow border.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits
39
The slide includes a summary table at the bottom showing Median Duration of Response (DoR) for the three patient cohorts.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action2 hits